Why do we need another PD-1/PD-L1 inhibitor?

Ross Soo
Dr Ross Soo addresses why we need another PD-1/PD-L1 inhibitor. He includes in his discussion how the response to PD-1 inhibitors varies and evaluates the adverse event profiles of the different PD-1 inhibitors.
Vídeos
4 out 2021

0P J:uu $\\ =Gl3Ullll K)j pE }nnu UO1M7p0 y/__|y/_I_ l1{lplU_1 Rj$t LekWk !=1 r3 Nc2C _0_OK_mKz. }g b## lg]5eyPg] hOA hg%% 12n GW Ob=w+x=i eu?01iM kQ ;U:VL;U:{V 9{-9d9d2/4, S,l M{T$}HTh \/\W//u joPH;\o ;BUIj {D{#{jr \J=[QQ=J rU =hXv Bi?kEQ@= aX! N)6 J1EWKTE1 s=%J~O `k11kbkO;1a`Y n&&&$TU!9 8l Ui9:[ 7bH87&&u%( o7K7vo *B6 ,kk }o\- \7 ~&Co~XCF~. (8 VZD/%IcZ em 6qV $7:D)::7y, 0P` pquY&c1bUi db $&5S&5Y T uC%C[z! |BW{BBs )aa`7*7S D[f =60_!_=h U/ YK/Y~Y/B~H He),mP)$.

i,9#,6_

Et}} Www

Inicie sessão ou registe-se para ter acesso total

Registar

Já tem uma conta?  Iniciar sessão